Preclinical evaluation of dual-labeled PSMA-inhibitors for the diagnosis and therapy of prostate cancer

被引：0
|
作者：
Baranski, Ann-Christin [3 ]
Schaefer, Martin [3 ]
Bauder-Wuest, Ulrike [3 ]
Roscher, Mareike [3 ]
Schmidt, Jana [3 ]
Stenau, Esther [2 ]
Simpfendoerfer, Tobias [5 ]
Maier-Hein, Lena [2 ]
Hadaschik, Boris [5 ]
Haberkorn, Uwe [1 ,4 ]
Eder, Matthias [1 ]
Kopka, Klaus [3 ]
机构：
[1] German Canc Res Ctr, Clin Cooperat Unit, Nucl Med, Heidelberg, Germany
[2] German Canc Res Ctr, Div Comp Assisted Med Intervent, Heidelberg, Germany
[3] German Canc Res Ctr, Div Radiopharmaceut Chem, Heidelberg, Germany
[4] Univ Hosp, Dept Nucl Med, Heidelberg, Germany
[5] Univ Hosp, Dept Urol, Heidelberg, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2017年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
531
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
    Luckerath, Katharina
    Wei, Liu
    Fendler, Wolfgang P.
    Evans-Axelsson, Susan
    Stuparu, Andreea D.
    Slavik, Roger
    Mona, Christine E.
    Calais, Jeremie
    Rettig, Matthew
    Reiter, Robert E.
    Herrmann, Ken
    Radu, Caius G.
    Czernin, Johannes
    Eiber, Matthias
    EJNMMI RESEARCH, 2018, 8
  • [42] Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
    Katharina Lückerath
    Liu Wei
    Wolfgang P. Fendler
    Susan Evans-Axelsson
    Andreea D. Stuparu
    Roger Slavik
    Christine E. Mona
    Jeremie Calais
    Matthew Rettig
    Robert E. Reiter
    Ken Herrmann
    Caius G. Radu
    Johannes Czernin
    Matthias Eiber
    EJNMMI Research, 8
  • [43] ANALYTICAL EVALUATION OF DUAL-LABELED SIMULTANEOUS ASSAYS FOR SERUM LH AND FSH
    BEINLICH, CJ
    PIPER, JA
    CLINICAL CHEMISTRY, 1985, 31 (06) : 963 - 963
  • [44] PET/NIRF imaging of liver cancer with a dual-labeled monoclonal antibody
    Ehlerding, Emily
    Hernandez, Reinier
    Sun, Haiyan
    Yang, Yunan
    England, Christopher
    Barnhart, Todd
    Cai, Weibo
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [45] Evaluation of new targeted alpha therapy using astatine (211At) labeled PSMA5 for prostate cancer
    Watabe, Tadashi
    Toyoshima, Atsushi
    Fukase, Koichi
    CANCER SCIENCE, 2023, 114 : 119 - 119
  • [46] Dual-labeled pertuzumab for multimodality preoperative and intraoperative imaging of ovarian cancer
    Lee, Hye Jin
    Ehlerding, Emily
    Jiang, Dawei
    Cao, Tianye
    Engle, Jonathan
    Cai, Weibo
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [47] PSMA Radioligand Therapy in Prostate Cancer
    Almeida, Ludmila Santiago
    Etchebehere, Elba Cristina Sa de Camargo
    Megias, Irene Garcia
    Teran, Adriana K. Calapaqui
    Hadaschik, Boris
    Colletti, Patrick M.
    Herrmann, Ken
    Giammarile, Francesco
    Bolton, Roberto C. Delgado
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (01) : 45 - 55
  • [48] Synthesis and preclinical evaluation of PSMA ligands labeled with astatine-211
    Shirakami, Yoshifumi
    Watabe, Tadashi
    Kadonaga, Yuichiro
    Kaneda, Kazuo
    Ooe, Kazuhiro
    Wang, Yang
    Haba, Hiromitsu
    Toyoshima, Atsushi
    Fukase, Koichi
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [49] Radiosynthesis and preclinical evaluation of a new Al18F-labeled Urea-based PSMA inhibitor for PET imaging of prostate cancer
    Cleeren, Frederik
    Lecina, Joan
    Ahamed, Muneer
    Holvoet, Bryan
    Deroose, Christophe
    Goffin, Karolien
    Verbruggen, Alfons
    Bormans, Guy
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [50] Synthesis and Preclinical Evaluation of Three Novel 68Ga-Labeled Bispecific PSMA/FAP-Targeting Tracers for Prostate Cancer Imaging
    Verena, Arsyangela
    Zhang, Zhengxing
    Kuo, Hsiou-Ting
    Merkens, Helen
    Zeisler, Jutta
    Wilson, Ryan
    Bendre, Shreya
    Wong, Antonio A. W. L.
    Benard, Francois
    Lin, Kuo-Shyan
    MOLECULES, 2023, 28 (03):
12345